⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
Form 8-K
sec.gov
MYGN
Myriad Genetics Reports Second Quarter 2026 Financial Results; Deploying New Initiatives Focused on Driving Increased Efficiency, Productivity and Scalability
globenewswire.com
MYGN
ZIRCON CORPORATION APPOINTS JACKIE ZOU AS CHIEF OPERATING OFFICER
prnewswire.com
MYGN
WDC
MRVL
IBM
Myriad Genetics to Release Second Quarter 2026 Financial Results on July 30, 2026
globenewswire.com
MYGN
Myriad Genetics Launches FirstGene® Multiple Prenatal Screen
globenewswire.com
MYGN
New Large-Scale Meta-Analysis Demonstrates Strong Prognostic Performance of Myriad’s Prolaris® Biopsy Test in Localized Prostate Cancer
globenewswire.com
MYGN
Form 8-K
sec.gov
SERA
MLAB
MYGN
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
prnewswire.com
ILMN
LLY
MYGN
Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication
globenewswire.com
MYGN
Form 8-K
sec.gov
MYGN